Early biological studies on the activity of the phytoestrogen in soy (isoflavones) have demonstrated that phytoestrogen can upregulate the estrogen receptor beta (ERbeta) and downregulate the estrogen receptor alpha (ERalpha), which then lead to the inhibition of prostate cancer cell proliferation [273]. This evidence concerns the gene ESR2 and prostate cancer.